Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and pharmaceutical science, 2-5-1 Shikata-cho,Okayama, 700-8558, Japan.
Brain Res. 2012 Mar 29;1446:109-18. doi: 10.1016/j.brainres.2011.12.064. Epub 2012 Jan 12.
The Kelch-like ECH-associated protein 1 (Keap1)/Nuclear erythroid 2-related factor 2 (Nrf2) system is the major cellular defense mechanism under oxidative stress, but the role in motor neuron degeneration under amyotrophic lateral sclerosis (ALS) pathology has not yet been fully elucidated. Here we examined temporal and spatial changes of Keap1, Nrf2, and their downstream stress response proteins heme oxgenase-1 (HO-1), glutathione, thioredoxin (TRX), and heat shock protein 70 (HSP70) throughout the course of motor neuron (MN) degeneration in the spinal cord of ALS model mice. Keap1 protein levels progressively decreased in the MN and anterior lumbar cord of ALS mice to 63% at early symptomatic 14 weeks and 58% at end symptomatic 18 weeks, while Nrf2 dramatically increased in the anterior lumbar cord with accumulation in the MN nucleus to 229% at 14 weeks and 471% at 18 weeks when glial like cells became also positive. In contrast, downstream stress response proteins such as HO-1, glutathione, TRX, and HSP70 showed only a small increase in MN with a significant increase to 149% to 280% in the number of glial-like cells after symptomatic 14 weeks. Our present observation suggests that MN selectively lost inductions of these important downstream protective proteins without regard to the Keap1/Nrf2 system activation, which could be a pivotal mechanism of neurodegenerative processes of ALS.
Kelch 样 ECH 相关蛋白 1(Keap1)/核红细胞 2 相关因子 2(Nrf2)系统是细胞在氧化应激下的主要防御机制,但在肌萎缩侧索硬化症(ALS)病理下对运动神经元变性的作用尚未完全阐明。在这里,我们检查了 Keap1、Nrf2 及其下游应激反应蛋白血红素加氧酶-1(HO-1)、谷胱甘肽、硫氧还蛋白(TRX)和热休克蛋白 70(HSP70)在 ALS 模型小鼠脊髓运动神经元(MN)变性过程中的时空变化。Keap1 蛋白水平在 ALS 小鼠的 MN 和前腰椎脊髓中逐渐下降,在早期症状性 14 周时降至 63%,在晚期症状性 18 周时降至 58%,而 Nrf2 在腰椎前侧脊髓中急剧增加,在 MN 核中积累,在 14 周时增加到 229%,在 18 周时增加到 471%,此时胶质样细胞也呈阳性。相比之下,HO-1、谷胱甘肽、TRX 和 HSP70 等下游应激反应蛋白在 MN 中仅略有增加,在症状出现后 14 周时胶质样细胞数量增加 149%至 280%。我们目前的观察结果表明,MN 选择性地失去了这些重要下游保护蛋白的诱导,而与 Keap1/Nrf2 系统的激活无关,这可能是 ALS 神经退行性过程的关键机制。